Beobachtungsplan, NIS 419: Case register study to capture the efficacy of Ipilimumab and other therapies after treatment with Nivolumab or Pembrolizumab in Ipilimumab naïve patients with stage IV or non-resectable stage III metastatic melanoma

Datei

• Artikel "Beobachtungsplan, NIS 419: Case register study to capture the efficacy of Ipilimumab and other therapies after treatment with Nivolumab or Pembrolizumab in Ipilimumab naïve patients with stage IV or non-resectable stage III metastatic melanoma"Herunterladen(PDF, 319KB, Datei ist nicht barrierefrei)